The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Drug Manufacturers - Major > Bristol-Myers Squibb Company

Bristol-Myers Squibb Company
NYSE: BMY
Change
symbol:
     
 NEWS FROM THE WIRES
WRAPUP 1-Bayer pulls Baycol in Japan, legal woes hit stock
Aug 23 2001 06:34 AM PDT

CBOE stats - U.S. equity options daily data
Aug 23 2001 06:34 AM PDT

Roche says near Brazil accord on AIDS drug price
Aug 23 2001 05:19 AM PDT

Lilly, Isis in reseach pact worth more than $300 mln
Aug 22 2001 05:03 AM PDT

Bayer pharma bidders seen stalling on Baycol fears
Aug 21 2001 09:53 AM PDT

More WIRE STORIES about this company

 NEWS FROM THE STANDARD
Drug Makers' Virtual Schmooze
Jun 12 2001 10:42 AM PDT

Bristol-Myers to Buy DuPont Drug Unit for $7.8 Billion
Jun 07 2001 05:22 PM PDT

After the Bell: Compaq Gains Following Earnings News
Jan 23 2001 05:17 PM PST

 PROFILE
Bristol-Myers Squibb is perhaps best known to the public as a stalwart of the personal care industry. Among its market-leading products are Clairol and Excedrin, but a majority of sales come from pharmaceuticals. The company focuses its efforts on cardiovascular treatments, anti-infective drugs, and cancer-fighting products; cholesterol-reduction drug Pravachol is its best-selling drug and cancer treatment TAXOL is #2. Bristol-Myers Squibb also makes baby formulas, wound treatments, and orthopedic products. The company is purchasing the pharmaceutical business of DuPont, which will give its drug pipeline a boost it sorely needs.

 COMPETITION
Aventis (AVE)
GlaxoSmithKline plc (GSK)
Merck & Co., Inc. (MRK)

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: December
2000 Sales (mil.): 18,216.00
1-Yr. Sales Growth: (9.9)%
Employees: 44,000
Revenue per employee: $414,000.00

 KEY PEOPLE
• Peter R. Dolan
    CEO
• Frederick S. Schiff
    CFO

 CONTACT INFO
345 Park Ave.
New York, NY 10154
US
Phone: 212-546-4000
Fax: 212-546-4020
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001